iBeta Receives Approval from DEA for Biometrics Testing

Aug. 2, 2012 - PRLog -- The Drug Enforcement Administration (DEA) has approved iBeta’s Certification Process for a Biometrics Subsystem for the Electronic Prescriptions for Controlled Substances (EPCS) pursuant to 21 Code of Federal Regulations (C.F.R) § 1311.300. This announcement can be found on the federal Registry site at https://www.federalregister.gov/articles/2012/08/01/2012-18748/electronic-prescriptions-for-controlled-substances-notice-of-approved-certification-process.
iBeta is now authorized to review, verify and certify that particular electronic prescribers or electronic pharmacy applications meet the requirements of DEA’s regulations governing EPCS.

The DEA-EPCS program allows practitioners, hospitals and pharmacies the option to utilize electronic prescriptions for controlled substances. The revised rule (June 1, 2010) allows the use of a biometric as a substitute for a hard token or a password.

The DEA notes that practitioners might find strong passwords more burdensome than a biometric or token over the long run. “Doctors and other prescribers are much less likely to leave their biometric at home, but if they forget their token I guess they will need to switch back to a pad for the day. Any technology that makes a physician’s day easier, benefits both the doctor and the patient.” said Dr. Wilson, iBeta’s Director of Biometrics.

About iBeta

Headquartered in Metro Denver (Aurora) Colorado, iBeta offers a full range of software quality services.  Our services encompass many different software quality activities, such as quality assurance, functionality testing, performance testing, compatibility testing, code reviews, IV & V, and test plan engineering. Our testing labs can handle a wide variety of software architectures, such as simple web-based applications, stand-alone software packages, and complex client-server architectures.

More information about iBeta’s biometrics department and its QA Testing services in general, can be found at iBeta’s website at http://www.iBeta.com.

Contact: Dr. Kevin Wilson PhD, kwilson@ibeta.com; 303-627-1110 Ext 177